skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Safety, efficacy, and patient acceptability of lidocaine hydrochloride ophthalmic gel as a topical ocular anesthetic for use in ophthalmic procedures

Review

(2967) Views  (1304) Full article downloads

Authors: Michael A Page, Frederick W Fraunfelder

Published Date October 2009 Volume 2009:3 Pages 601 - 609
DOI: http://dx.doi.org/10.2147/OPTH.S4935

Michael A Page, Frederick W Fraunfelder

Department of Ophthalmology (Casey Eye Institute), Oregon Health and Science University, Portland, OR, USA

Purpose: To review the current literature on safety, efficacy, and measures of surgeon and patient satisfaction with lidocaine hydrochloride gel as a tool for ocular anesthesia.

Methods: Pubmed search using keywords “lidocaine gel,” “ophthalmic,” and “surgery” and compiling cross-references. Twenty-six total references were reviewed, including 15 prospective randomized controlled trials (RCTs, total N = 933, average N = 62), 6 nonrandomized prospective studies (total N = 234, average N = 39), 2 animal studies, 1 microbiologic study, and 2 letters to the editor.

Results: The RCTs and nonrandomized prospective studies evaluated a number of measures including timing of onset of anesthesia, duration of anesthesia, intraoperative and postoperative pain, need for additional anesthetic applications, intracameral lidocaine levels, and adverse effects. Control groups received topical drops, subconjunctival anesthetic, retrobulbar anesthetic, or sham gel. Lidocaine gel was shown to be at least as effective for pain control as alternative therapies in all studies, with longer duration of action than topical drops. Patient and surgeon satisfaction were high, and adverse effects were rare and comparable to those for anesthetic drop formulations. Surgical settings included cataract, pterygium, trabeculectomy, strabismus, intravitreal injection, vitrectomy, and penetrating keratoplasty.

Conclusions: Lidocaine gel is a safe, effective, and potentially underutilized tool for ophthalmic surgery.

Keywords: lidocaine, gel, topical, ophthalmic, ocular, anesthetic








Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension
Characteristics of respondents with glaucoma and dry eye in a national panel survey
First-year treatment costs among new initiators of topical prostaglandin analogs
Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides
Bevacizumab (Avastin®) for the management of anterior chamber neovascularization and neovascular glaucoma
A novel lidocaine hydrochloride ophthalmic gel for topical ocular anesthesia
Tetracaine 0.5% eyedrops with or without lidocaine 2% gel in topical anesthesia for cataract surgery
Outcome predictors for treatment success with 5% lidocaine medicated plaster in low back pain with neuropathic components and neuropathic pain after surgical and nonsurgical trauma
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy